Tablet induced dysphagia in oesophageal cancer.
Selinger
C P
CP
Clements
D G
DG
D000230:Adenocarcinoma / Q000150:complications*; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000369:Aged, 80 and over; D003680:Deglutition Disorders / Q000209:etiology*; D003692:Delayed-Action Preparations / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000150:complications*; D004945:Esophagoscopy; D006801:Humans; D008297:Male; D011799:Quinazolines / Q000008:administration & dosage; D013607:Tablets / Q000009:adverse effects*
D000317:Adrenergic alpha-Antagonists; D003692:Delayed-Action Preparations; D011799:Quinazolines; D013607:Tablets; C047638:alfuzosin